[02 October 2013]
Products Affected - Description
Antivenin latrodectus mactans (Black Widow Spider Antivenin) (NDC 00006-4084-00), Merck
Reason for the Shortage
Merck has low inventory of Antivenin Latrodectus Mactans.
No presentations are fully available.
Estimated Resupply Dates
Emergency supplies are available for patients with symptoms due to a bite by the black widow spider within 24 hours of contacting Merck. The company cannot estimate when regular distribution will resume.
October 2, 2013; July 18, 2013; May 14, 2013; March 20, 2013; January 28, 2013; November 7, 2012; October 1, 2012; August 8, 2012; May 4, 2012; March 7, 2012; January 10, 2012; November 4, 2011; September 2, 2011; July 26, 2011; June 2, 2011; April 26, 2011; March 16, 2011; February 2, 2011; December 29, 2010; August 5, 2010; May 24, 2010; March 17, 2010; January 25, 2010; December 7, 2009; October 19, 2009; September 2, 2009; May 15, 2009; April 20, 2009; March 5, 2009, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins